Who invested in Lux Biosciences?
Lux Biosciences's investors include SV Life Sciences, Novo Holdings A/S, HBM BioVentures and Prospect Venture Partners.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$90Mraised across 6 rounds since 2009, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $16M sold, first sale Feb 2012
No investor was named in the report.
Reported by sec.govSEC filing: $4.0M sold, first sale Dec 2011
No investor was named in the report.
Reported by sec.govSEC filing: $6.0M sold, first sale Jun 2011
No investor was named in the report.
From a historical funding recordSEC filing: $5.0M sold, first sale Dec 2010
Reported by venturebeat.comSEC filing: $38M sold, first sale Oct 2009
No investor was named in the report.
From a historical funding recordSEC filing: $9.2M sold, first sale Jun 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Lux Biosciences's investors include SV Life Sciences, Novo Holdings A/S, HBM BioVentures and Prospect Venture Partners.
Lux Biosciences has raised $90M across 6 rounds since 2009.
Lux Biosciences's most recent round was a Debt of $16M in Mar 2012.
Lux Biosciences's largest round on record is $50M (Series B), in Oct 2009.
Lux Biosciences's first round on record, in Oct 2009, was backed by SV Life Sciences, Novo Holdings A/S and HBM BioVentures and 1 others.
Lux Biosciences's latest named round is a Debt, in Mar 2012.
Lux Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.